{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T05:45:55Z","timestamp":1791870355390,"version":"4.3.4"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2025,5,10]],"date-time":"2025-05-10T00:00:00Z","timestamp":1746835200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,5,10]],"date-time":"2025-05-10T00:00:00Z","timestamp":1746835200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100024211","name":"Acibadem Mehmet Ali Aydinlar University","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100024211","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pediatr Cardiol"],"published-print":{"date-parts":[[2026,3]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Homografts conduits has been the gold standard for right ventricle to pulmonary artery (RV-PA) conduit. Several different types of xenograft valved conduits have been used as an alternative to homografts, due to their limited availability. In this single center, retrospective study, we analyzed the outcomes of patients with bovine jugular vein conduit (Contegra) and porcine valved conduit (Biointegral) in terms of survival and reintervention rate. Between 2012 and 2023, 44 children underwent surgical repair with RV-PA conduits using Contegra (\n                    <jats:italic>n<\/jats:italic>\n                    \u2009=\u200920) or Biointegral (\n                    <jats:italic>n<\/jats:italic>\n                    \u2009=\u200924). Patients with truncus arteriosus and patients who underwent unifocalization and Ross procedures were excluded. The operations in which other RV-PA conduits such as homografts, Gore-Tex grafts with PTFE handmade valved were used, were also excluded from the study. The median age of the patients was 19 (3\u201360) months and 84% of the patients (\n                    <jats:italic>n<\/jats:italic>\n                    \u2009=\u200937) had a history of previous intervention. Hospital mortality was 4.5% (\n                    <jats:italic>n<\/jats:italic>\n                    \u2009=\u20092). The median length of stay in intensive care unit and hospital was 5 (2\u201363) and 19 (2\u2013145) days, respectively. 36 of the patients (82%) were followed for a median of 68 (4.8\u2013143.7) months. There was one late death in Contegra group and five late deaths in Biointegral group. Survival analysis revealed that 1, 5, and 10-year survival rates were 100%, 90%, and 90% in Contegra group and 81%, 76.2%, and 33.9% (\n                    <jats:italic>p<\/jats:italic>\n                    \u2009=\u20090.047) in Biointegral group, respectively. During follow-up period, 11 patients (30.5%) needed reintervention (\n                    <jats:italic>n<\/jats:italic>\n                    \u2009=\u20093 in Contegra;\n                    <jats:italic>n<\/jats:italic>\n                    \u2009=\u20098 in Biointegral group). Freedom from reintervention rates were 100%, 94.1%, and 47.1% at 1, 5, and 10\u00a0years in Contegra group and 100% and 63.3% at 1 and 5\u00a0years in Biointegral group, respectively (\n                    <jats:italic>p<\/jats:italic>\n                    \u2009=\u20090.024). In this study, the outcomes of Contegra conduits were statistically significantly better than Biointegral conduits. Contegra is still the most valuable alternative to homografts. We believe that the choice of conduit in the first surgery is an important decision that directly affects survival and re-intervention rates.\n                  <\/jats:p>","DOI":"10.1007\/s00246-025-03885-7","type":"journal-article","created":{"date-parts":[[2025,5,10]],"date-time":"2025-05-10T05:27:25Z","timestamp":1746854845000},"page":"1135-1141","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Outcomes of Bovine Jugular Vein Versus Porcine Valved Conduits for Right Ventricle to Pulmonary Artery Connection"],"prefix":"10.1007","volume":"47","author":[{"given":"Bahar","family":"Temur","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ibrahim","family":"Gokce","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yakup","family":"Tire","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zeynep Sila","family":"Ozcan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Selim","family":"Aydin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tugcin Bora","family":"Polat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ersin","family":"Erek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,5,10]]},"reference":[{"key":"3885_CR1","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1016\/S0022-5223(98)70312-5","volume":"115","author":"J Stark","year":"1998","unstructured":"Stark J, Bull C, Stajevic M, Jothi M, Elliott M, de Leval M (1998) Fate of subpulmonary homograft conduits: determinants of late homograft failure. J Thorac Cardiovasc Surg 115:506\u2013516","journal-title":"J Thorac Cardiovasc Surg"},{"key":"3885_CR2","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1016\/j.athoracsur.2005.02.053","volume":"80","author":"JW Brown","year":"2005","unstructured":"Brown JW, Ruzmetov M, Rodefeld MD, Vijay P, Turrentine MW (2005) Right ventricular outflow tract reconstruction with an allograft conduit in non-Ross patients: risk factors for allograft dysfunction and failure. Ann Thorac Surg 80:655\u2013663","journal-title":"Ann Thorac Surg"},{"key":"3885_CR3","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1177\/021849230301100114","volume":"11","author":"E Erek","year":"2003","unstructured":"Erek E, Yalcinbas YK, Salihoglu E, Ozturk N, Arat S, Sarioglu A, Samanli UB, Sarioglu T (2003) Fate of stentless bioprosthesis on the right side of the heart. Asian Cardiovasc Thorac Ann 11:58\u201362","journal-title":"Asian Cardiovasc Thorac Ann"},{"key":"3885_CR4","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1016\/j.jtcvs.2015.10.100","volume":"151","author":"B Alsoufi","year":"2016","unstructured":"Alsoufi B (2016) Right ventricle-to-pulmonary artery conduits: do we really have an option? J Thorac Cardiovasc Surg 151:442\u2013443","journal-title":"J Thorac Cardiovasc Surg"},{"key":"3885_CR5","doi-asserted-by":"crossref","unstructured":"Abolhoda A, Sumei Y, Oyarzun R, Allen KR, Cormick JRM, Shenggao H et al (1996) No-react detoxification process: a superior anticalcification method for bioprostheses. Ann Thorac Surg 62:1724\u20131730","DOI":"10.1016\/S0003-4975(96)00948-4"},{"issue":"2","key":"3885_CR6","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1007\/s12055-020-01050-8","volume":"37","author":"KS Iyer","year":"2021","unstructured":"Iyer KS (2021) Valved conduits in the right ventricular outflow: the Achilles heel of congenital heart surgery. Indian J Thorac Cardiovasc Surg 37(2):127\u2013128","journal-title":"Indian J Thorac Cardiovasc Surg"},{"key":"3885_CR7","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1067\/mtc.2002.121158","volume":"124","author":"WJ Wells","year":"2002","unstructured":"Wells WJ, Arroyo H Jr, Bremner RM, Wood J, Starnes VA (2002) Homograft conduit failure in infants is not due to somatic outgrowth. J Thorac Cardiovasc Surg 124:88\u201396","journal-title":"J Thorac Cardiovasc Surg"},{"key":"3885_CR8","doi-asserted-by":"publisher","first-page":"1539","DOI":"10.1007\/s00246-022-02881-5","volume":"43","author":"PO Veillette","year":"2022","unstructured":"Veillette PO, Miro J, Khairy P, Abadir S, Le Bloa M (2022) Ventricular arrhythmias and sudden death following percutaneous pulmonary valve implantation in pediatric patients. Pediatr Cardiol 43:1539\u20131547","journal-title":"Pediatr Cardiol"},{"key":"3885_CR9","doi-asserted-by":"publisher","first-page":"365","DOI":"10.5606\/tgkdc.dergisi.2018.14841","volume":"26","author":"E Erek","year":"2018","unstructured":"Erek E, Temur B, Suzan D, Ayd\u0131n S, Yildiz O, K\u0131rat B, Demir IH, Odemis E (2018) Outcomes of truncus arteriosus repair with bovine jugular vein conduit. Turk Gogus Kalp Dama 26:365\u2013369","journal-title":"Turk Gogus Kalp Dama"},{"key":"3885_CR10","first-page":"541","volume":"2","author":"J Brown","year":"2011","unstructured":"Brown J, Ruzmetov M, Rodefeld MD, Eltayeb O, Yurdakok O, Turrentine MW (2011) Contegra versus pulmonary homografts for right ventricular outflow tract reconstruction: a ten year single institution comparison. World J Ped Cong Heart Dis 2:541\u2013549","journal-title":"World J Ped Cong Heart Dis"},{"key":"3885_CR11","doi-asserted-by":"publisher","first-page":"1022","DOI":"10.1067\/mtc.2000.110684","volume":"120","author":"CA Caldarone","year":"2000","unstructured":"Caldarone CA, McCrindle BW, Van Arsdell GS, Coles JG, Webb G, Freedom RM et al (2000) Independent factors associated with longevity of prosthetic pulmonary valves and valved conduits. J Thorac Cardiovasc Surg 120:1022\u20131030","journal-title":"J Thorac Cardiovasc Surg"},{"key":"3885_CR12","doi-asserted-by":"publisher","first-page":"1572","DOI":"10.21037\/tp-23-80","volume":"12","author":"AG Harris","year":"2023","unstructured":"Harris AG, Lacobazzi D, Caputo M, Bartoli-Leonard F (2023) Graft rejection in paediatric congenital heart disease. Transl Pediatr 12:1572\u20131591","journal-title":"Transl Pediatr"},{"key":"3885_CR13","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1016\/j.jtcvs.2008.08.060","volume":"137","author":"M Ando","year":"2009","unstructured":"Ando M, Takahashi Y (2009) Ten-year experience with handmade trileaflet polytetrafluoroethylene valved conduit used for pulmonary reconstruction. J Thorac Cardiovasc Surg 137:124\u2013131","journal-title":"J Thorac Cardiovasc Surg"},{"key":"3885_CR14","doi-asserted-by":"publisher","first-page":"1274","DOI":"10.1093\/ejcts\/ezaa240","volume":"58","author":"S Fujita","year":"2020","unstructured":"Fujita S, Yamagishi M, Miyazaki T, Maeda Y, Itatani K, Yamamoto Y, Asada S et al (2020) Long-term results of large-calibre expanded polytetrafluoroethylene valved conduits with bulging sinuses. Eur J Cardiothorac Surg 58:1274\u20131280","journal-title":"Eur J Cardiothorac Surg"},{"key":"3885_CR15","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1016\/j.jtcvs.2010.06.068","volume":"141","author":"FS Schoenhoff","year":"2011","unstructured":"Schoenhoff FS, Loup O, Gahl B, Banz Y, Pavlovic M, Pfammatter JP, Carrel TP, Kadner A (2011) The Contegra bovine jugular vein graft versus the Shelhigh pulmonic porcine graft for reconstruction of the right ventricular outflow tract: a comparative study. J Thorac Cardiovasc Surg 141:654\u2013661","journal-title":"J Thorac Cardiovasc Surg"},{"key":"3885_CR16","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1055\/s-0029-1185513","volume":"57","author":"T Breymann","year":"2009","unstructured":"Breymann T, Balnz U, Wojtalik MA, Hetzer R, Sarris G, Stellin G, Planche C, Tsang V, Weissmann N, Boethig D (2009) European Contegra multicentre study: 7 years results after 165 valved bovine jugular vein graft implantations. Thorac Cardiov Surg 57:257\u2013269","journal-title":"Thorac Cardiov Surg"},{"key":"3885_CR17","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1186\/1749-8090-3-62","volume":"3","author":"AD Protopapas","year":"2008","unstructured":"Protopapas AD, Athanasiou T (2008) Contegra conduit for reconstruction of the right ventricular outflow tract: a review of published early and mid-time results. J Cardiothorac Surg 3:62","journal-title":"J Cardiothorac Surg"},{"key":"3885_CR18","doi-asserted-by":"crossref","unstructured":"Hickey EJ, Mc Crindle BW, Blackstone EH, Yeh T, Pigula F, Clarke D, Tchervenkov CI, Hawkins J, CHSS Pulmonary Conduit Working Group (2008) Jugular venous valved conduit (Contegra) matches allograft performance in infant truncus arteriosus repair. Eur J Cardiothorac Surg 33:890\u2013898","DOI":"10.1016\/j.ejcts.2007.12.052"},{"key":"3885_CR19","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1016\/S0003-4975(02)04547-2","volume":"75","author":"JA Dearani","year":"2003","unstructured":"Dearani JA, Danielson GK, Puga FJ, Schaff HV, Warnes CW, Driscoll DJ et al (2003) Late follow-up of 1095 patients undergoing operation for complex congenital heart disease utilizing pulmonary ventricle to pulmonary artery conduits. Ann Thorac Surg 75:399\u2013410","journal-title":"Ann Thorac Surg"},{"key":"3885_CR20","doi-asserted-by":"publisher","first-page":"34","DOI":"10.4103\/0974-2069.93707","volume":"5","author":"KS Iyer","year":"2012","unstructured":"Iyer KS (2012) The Contegra bovine jugular valved conduit: living up to expectations? Ann Pediatr Cardiol 5:34\u201335","journal-title":"Ann Pediatr Cardiol"}],"container-title":["Pediatric Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00246-025-03885-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00246-025-03885-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00246-025-03885-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,12]],"date-time":"2026-02-12T07:01:57Z","timestamp":1770879717000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00246-025-03885-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,10]]},"references-count":20,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,3]]}},"alternative-id":["3885"],"URL":"https:\/\/doi.org\/10.1007\/s00246-025-03885-7","relation":{},"ISSN":["0172-0643","1432-1971"],"issn-type":[{"value":"0172-0643","type":"print"},{"value":"1432-1971","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,10]]},"assertion":[{"value":"26 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 April 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 May 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}